A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...
The analysis identifies four main pathogenetic categories: entities characterized by senescence, sharing clinical features with idiopathic pulmonary fibrosis (IPF), including subsets of fibrosing ...
We quantified the proportion of diagnoses of pulmonary fibrosis (PF) among 25 136 people with lung cancer and 250 583 matched ...
Background A usual interstitial pneumonia (UIP) pattern of lung injury is a key feature of idiopathic pulmonary fibrosis (IPF) and is also observed in up to 40% of individuals with rheumatoid ...
Garadacimab is under clinical development by CSL and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData, Phase II drugs for Idiopathic Pulmonary Fibrosis have a 35% phase ...
What Is a Pulmonary Embolism? A pulmonary embolism (PE) happens when a blood clot suddenly blocks an artery that supplies blood to your lungs. Pulmonary embolism happens when a blood clot travels ...
A pair of studies presented at the European Respiratory Society Congress 2024 emphasized the importance of close monitoring ...
A study in Frontiers of Medicine explores the role of the m 6 A reader YTHDF1 in cardiac fibrosis, a condition characterized by the excessive accumulation of extracellular matrix proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback